Compare Amylx Pharmaceuticals Inc (AMLX) vs Standard Lithium Ltd (SLI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amylx Pharmaceuticals Inc vs Standard Lithium Ltd — how do they compare? Amylx Pharmaceuticals Inc trades at $23.65 (market cap $2.64B), while Standard Lithium Ltd trades at $2.41 (market cap $604.50M). The key difference: Amylx Pharmaceuticals Inc is far larger — about 4.4× Standard Lithium Ltd's market cap, and Amylx Pharmaceuticals Inc is trading nearer its 52-week high, Standard Lithium Ltd nearer its low. Which is the better fit depends on your goals.
| AMLX | SLI | |
|---|---|---|
Market Cap | $2.64B | $604.50M |
Sector | Health | Basic Materials |
52-Week High | $24.19 | $5.65 |
52-Week Low | $7.82 | $1.93 |
Enterprise Value | $2.39B | $467.42M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →About Standard Lithium Ltd
Standard Lithium Ltd. is a company focused on the development of lithium projects in North America, with a primary focus on extracting lithium from brine resources. Their flagship projects aim to utilize proprietary, advanced direct lithium extraction (DLE) technologies to produce high-purity lithium compounds in an environmentally responsible manner. The company seeks to become a key domestic supplier to the growing electric vehicle and battery storage markets.
Read more on SLI →
